These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8386345)
21. The role of the mu 2-opioid receptor in the antitussive effect of morphine in mu 1-opioid receptor-deficient CXBK mice. Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y Eur J Pharmacol; 1993 Aug; 240(1):99-101. PubMed ID: 8405130 [TBL] [Abstract][Full Text] [Related]
22. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice. Ohsawa M; Nagase H; Kamei J J Pharmacol Exp Ther; 1998 Aug; 286(2):780-7. PubMed ID: 9694934 [TBL] [Abstract][Full Text] [Related]
23. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Noble F; Cox BM Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358 [TBL] [Abstract][Full Text] [Related]
24. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related]
25. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation. Chakrabarti S; Law PY; Loh HH J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870 [TBL] [Abstract][Full Text] [Related]
26. Effects of prenatal morphine and adult estrogen administration on mu-opioid inhibition of norepinephrine release from hypothalamic slices. Vathy I; Etgen AM Neuroendocrinology; 1996 Jan; 63(1):61-8. PubMed ID: 8839356 [TBL] [Abstract][Full Text] [Related]
27. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269 [TBL] [Abstract][Full Text] [Related]
28. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO). Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM J Pharmacol Exp Ther; 1992 Aug; 262(2):526-31. PubMed ID: 1380079 [TBL] [Abstract][Full Text] [Related]
29. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. Ward SJ; Takemori AE J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119 [TBL] [Abstract][Full Text] [Related]
30. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973 [TBL] [Abstract][Full Text] [Related]
31. In vivo injection of antibodies directed against the cloned mu opioid receptor blocked supraspinal analgesia induced by mu-agonists in mice. Garzón J; Sánchez-Blázquez P Life Sci; 1995; 56(14):PL237-42. PubMed ID: 7475889 [TBL] [Abstract][Full Text] [Related]
32. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
33. Regulation of L-valine absorption by opioids interacting with mu-receptors in rabbit ileum. Meyer G; Bottà G; Fedele G; Cremaschi D Experientia; 1995 Nov; 51(11):1045-51. PubMed ID: 7498442 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of mu and delta opioid binding sites in striatal slices of morphine-tolerant and -dependent mice. Abdelhamid EE; Takemori AE Eur J Pharmacol; 1991 Jun; 198(2-3):157-63. PubMed ID: 1650700 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909 [TBL] [Abstract][Full Text] [Related]
36. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Yabaluri N; Medzihradsky F Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981 [TBL] [Abstract][Full Text] [Related]
37. Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats. Mao J; Price DD; Lu J; Mayer DJ Neurosci Lett; 1998 Jul; 250(3):193-6. PubMed ID: 9708865 [TBL] [Abstract][Full Text] [Related]
38. An examination of the relationship between mu-opioid antinociceptive efficacy and G-protein coupling using pertussis and cholera toxins. Goode TL; Raffa RB Life Sci; 1997; 60(7):PL107-13. PubMed ID: 9042382 [TBL] [Abstract][Full Text] [Related]
40. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats. Sbacchi M; La Regina A; Petrillo P; Tavani A NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]